Armin Rabsteyn

1.3k total citations
13 papers, 179 citations indexed

About

Armin Rabsteyn is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Armin Rabsteyn has authored 13 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Armin Rabsteyn's work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and vaccines and immunoinformatics approaches (3 papers). Armin Rabsteyn is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and vaccines and immunoinformatics approaches (3 papers). Armin Rabsteyn collaborates with scholars based in Germany, France and United States. Armin Rabsteyn's co-authors include Dennis Lindau, Hans‐Georg Rammensee, Gosse J. Adema, Marie‐Christophe Boissier, Ina Kötter, Julie Mussard, Patrice Decker, M Ribon, Peter Lang and Rupert Handgretinger and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and British Journal of Haematology.

In The Last Decade

Armin Rabsteyn

11 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armin Rabsteyn Germany	6	110	50	45	38	35	13	179
Laura Todi Italy	10	59 0.5×	34 0.7×	26 0.6×	27 0.7×	31 0.9×	17	278
Karen L. Bride United States	4	105 1.0×	34 0.7×	34 0.8×	97 2.6×	39 1.1×	7	234
Katrin Thorarinsdottir Sweden	9	209 1.9×	28 0.6×	42 0.9×	17 0.4×	59 1.7×	11	285
Dana Vu Van Germany	8	275 2.5×	48 1.0×	59 1.3×	22 0.6×	25 0.7×	8	361
Ingeborg Steiert Germany	9	213 1.9×	33 0.7×	28 0.6×	40 1.1×	46 1.3×	13	296
Martin van Hagen Netherlands	7	105 1.0×	33 0.7×	28 0.6×	28 0.7×	109 3.1×	16	284
Steven Hanson United Kingdom	6	156 1.4×	17 0.3×	28 0.6×	37 1.0×	14 0.4×	8	218
Masanori Makita Japan	7	139 1.3×	80 1.6×	168 3.7×	56 1.5×	12 0.3×	21	270
Katie Perkins United States	4	154 1.4×	23 0.5×	52 1.2×	49 1.3×	12 0.3×	8	216
Susan Swee‐Shan Hue Singapore	7	136 1.2×	56 1.1×	128 2.8×	17 0.4×	27 0.8×	21	301

Countries citing papers authored by Armin Rabsteyn

Since Specialization

Citations

This map shows the geographic impact of Armin Rabsteyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Rabsteyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Rabsteyn more than expected).

Fields of papers citing papers by Armin Rabsteyn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Rabsteyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Rabsteyn. The network helps show where Armin Rabsteyn may publish in the future.

Co-authorship network of co-authors of Armin Rabsteyn

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Rabsteyn. A scholar is included among the top collaborators of Armin Rabsteyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Rabsteyn. Armin Rabsteyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Zelba, Henning, Christina Kyzirakos, Simone Kayser, et al.. (2024). Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy. Vaccines. 12(4). 397–397. 1 indexed citations

Zelba, Henning, Armin Rabsteyn, Oliver Bartsch, et al.. (2023). Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. Frontiers in Immunology. 14. 1271449–1271449. 4 indexed citations

Zelba, Henning, Armin Rabsteyn, Oliver Bartsch, et al.. (2022). Adjuvant Treatment for Breast Cancer Patients Using Individualized Neoantigen Peptide Vaccination—A Retrospective Observation. Vaccines. 10(11). 1882–1882. 7 indexed citations

Holzer, Ursula, Christian Seitz, Armin Rabsteyn, et al.. (2022). Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy. The Pediatric Infectious Disease Journal. 41(6). e259–e262.

Lang, Peter, Tamam Bakchoul, Hans Bösmüller, et al.. (2020). Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients. Journal of the Pediatric Infectious Diseases Society. 9(5). 622–625. 13 indexed citations

Blaeschke, Franziska, Milan Paul, Martin U. Schuhmann, et al.. (2019). Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. Cytotherapy. 21(9). 973–986. 31 indexed citations

Schlegel, Patrick, Annemarie Lang, Christian Seitz, et al.. (2019). Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity. Bone Marrow Transplantation. 54(S2). 727–732. 5 indexed citations

Rabsteyn, Armin, Christina Kyzirakos, Christopher Schroeder, et al.. (2019). Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients. Cancer Immunology Research. 7(2_Supplement). B124–B124.

Schlegel, Patrick, Latifa Zekri, Sabine Schleicher, et al.. (2019). Abstract A131: Targeting B7-H3 (CD276) in neuroblastoma: In vitro evaluation of Fc-optimized antibodies and immunocytokines. Cancer Immunology Research. 7(2_Supplement). A131–A131. 2 indexed citations

10.

Ebinger, Martin, Tobias Feuchtinger, Heiko‐Manuel Teltschik, et al.. (2017). CD34⁺ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation. British Journal of Haematology. 180(1). 90–99. 34 indexed citations

11.

Lindau, Dennis, Julie Mussard, Armin Rabsteyn, et al.. (2013). TLR9 independent interferon α production by neutrophils on NETosis in response to circulating chromatin, a key lupus autoantigen. Annals of the Rheumatic Diseases. 73(12). 2199–2207. 78 indexed citations

12.

Lindau, Dennis, Armin Rabsteyn, Julie Mussard, et al.. (2012). OP0255 TLR9-independent and immune complex-independent interferon-alpha production by neutrophils upon netosis in response to circulating chromatin. Annals of the Rheumatic Diseases. 71. 142–142. 3 indexed citations

13.

Lindau, Dennis, et al.. (2011). Chromatin-activated neutrophils represent a major source of interferon α. Annals of the Rheumatic Diseases. 70. A38–A39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact